Myriad Genetics Inc (MYGN) — Cash Flow-to-Debt Ratio
Myriad Genetics Inc (MYGN) has a Cash Flow-to-Debt Ratio of 0.03x as of December 2025, meaning its operating cash flow of $10.60 Million could theoretically repay 0% of its total liabilities ($338.60 Million) in one year. See how much free cash does Myriad Genetics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Myriad Genetics Inc Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Myriad Genetics Inc across 30 annual periods. Also explore MYGN net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Myriad Genetics Inc (1995–2025)
Year-by-year debt coverage analysis for Myriad Genetics Inc. For market capitalisation and broader financial context, see Myriad Genetics Inc (MYGN) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $1.80 Million | $338.60 Million | ▲ +120.0% |
| 2024 | -0.03x | $-8.70 Million | $326.50 Million | ▲ +91.3% |
| 2023 | -0.31x | $-110.90 Million | $363.30 Million | ▲ +10.1% |
| 2022 | -0.34x | $-106.30 Million | $312.90 Million | ▼ -744.6% |
| 2021 | 0.05x | $18.60 Million | $352.90 Million | ▼ -66.1% |
| 2020 | 0.16x | $83.70 Million | $537.80 Million | ▼ -11.9% |
| 2019 | 0.18x | $83.70 Million | $473.80 Million | ▼ -68.1% |
| 2018 | 0.55x | $115.90 Million | $209.20 Million | ▲ +133.0% |
| 2017 | 0.24x | $106.20 Million | $446.60 Million | ▼ -81.1% |
| 2016 | 1.26x | $166.30 Million | $132.40 Million | ▼ -6.9% |
| 2015 | 1.35x | $140.50 Million | $104.10 Million | ▼ -25.6% |
| 2014 | 1.81x | $190.20 Million | $104.82 Million | ▼ -21.5% |
| 2013 | 2.31x | $173.90 Million | $75.23 Million | ▼ -10.4% |
| 2012 | 2.58x | $141.80 Million | $54.98 Million | ▼ -13.2% |
| 2011 | 2.97x | $130.83 Million | $44.03 Million | ▼ -30.5% |
| 2010 | 4.28x | $155.09 Million | $36.27 Million | ▲ +63.9% |
| 2009 | 2.61x | $84.04 Million | $32.20 Million | ▲ +85.4% |
| 2008 | 1.41x | $103.74 Million | $73.69 Million | ▲ +272.7% |
| 2007 | -0.82x | $-25.85 Million | $31.70 Million | ▲ +22.0% |
| 2006 | -1.04x | $-28.03 Million | $26.82 Million | ▼ -4.4% |
| 2005 | -1.00x | $-23.30 Million | $23.29 Million | ▲ +51.1% |
| 2004 | -2.05x | $-30.88 Million | $15.08 Million | ▲ +14.9% |
| 2003 | -2.41x | $-46.54 Million | $19.34 Million | ▼ -320.8% |
| 2002 | -0.57x | $-16.31 Million | $28.52 Million | ▼ -393.6% |
| 2001 | -0.12x | $-3.78 Million | $32.58 Million | ▼ -119.4% |
| 2000 | 0.60x | $17.16 Million | $28.67 Million | ▲ +122.9% |
| 1999 | -2.61x | $-14.10 Million | $5.40 Million | ▼ -269.3% |
| 1998 | -0.71x | $-7.00 Million | $9.90 Million | ▼ -6.1% |
| 1997 | -0.67x | $-6.60 Million | $9.90 Million | ▼ -547.6% |
| 1995 | 0.15x | $1.40 Million | $9.40 Million | — |